Reduction in Cardiovascular Events by Acadesine in Patients Undergoing CABG - RED-CABG

Description:

The goal of the trial was to evaluate treatment with the adenosine-regulating agent acadesine compared with placebo among patients undergoing coronary artery bypass grafting (CABG).